Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea

医学 糖尿病性视网膜病变 糖尿病 内科学 蛋白尿 血糖性 视网膜病变 2型糖尿病 危险系数 2型糖尿病 英国前瞻性糖尿病研究 入射(几何) 前瞻性队列研究 置信区间 内分泌学 物理 光学
作者
Jae-Seung Yun,Tae-Seok Lim,Seon‐Ah Cha,Yu‐Bae Ahn,Ki-Ho Song,Jin A Choi,Jin Woo Kwon,Donghyun Jee,Yang Kyung Cho,Yong‐Moon Park,Seung‐Hyun Ko
出处
期刊:Diabetes & Metabolism Journal [Korean Diabetes Association]
卷期号:40 (6): 482-482 被引量:47
标识
DOI:10.4093/dmj.2016.40.6.482
摘要

We investigated clinical course and risk factors for diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM).A total of 759 patients with T2DM without DR were included from January 2001 to December 2004. Retinopathy evaluation was performed at least annually by ophthalmologists. The severity of the DR was classified into five categories according to the International Clinical Diabetic Retinopathy Severity Scales.Of the 759 patients, 523 patients (68.9%) completed the follow-up evaluation. During the follow-up period, 235 patients (44.9%) developed DR, and 32 patients (13.6%) progressed to severe nonproliferative DR (NPDR) or proliferative DR (PDR). The mean duration of diabetes at the first diagnosis of mild NPDR, moderate NPDR, and severe NPDR or PDR were 14.8, 16.7, and 17.3 years, respectively. After adjusting multiple confounding factors, the significant risk factors for the incidence of DR risk in patients with T2DM were old age, longer duration of diabetes, higher mean glycosylated hemoglobin (HbA1c), and albuminuria. Even in the patients who had been diagnosed with diabetes for longer than 10 years at baseline, a decrease in HbA1c led to a significant reduction in the risk of developing DR (hazard ratio, 0.73 per 1% HbA1c decrement; 95% confidence interval, 0.58 to 0.91; P=0.005).This prospective cohort study demonstrates that glycemic control, diabetes duration, age, and albuminuria are important risk factors for the development of DR. More aggressive retinal screening for T2DM patients diagnosed with DR should be required in order to not miss rapid progression of DR.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
完美世界应助安w采纳,获得10
1秒前
传奇3应助董家旭采纳,获得10
2秒前
xxzz完成签到,获得积分10
2秒前
1234发布了新的文献求助10
3秒前
我是老大应助霸气的念薇采纳,获得30
5秒前
zzx应助keyanlv采纳,获得30
5秒前
Whl完成签到,获得积分10
6秒前
cssfsa发布了新的文献求助30
6秒前
7秒前
7秒前
李昕123完成签到 ,获得积分10
7秒前
王往往完成签到 ,获得积分10
8秒前
苏木发布了新的文献求助10
12秒前
zcc发布了新的文献求助10
12秒前
16秒前
高兴莆完成签到 ,获得积分10
17秒前
Jasper应助Eurus采纳,获得10
18秒前
wenchong完成签到,获得积分10
21秒前
朱子怡发布了新的文献求助10
21秒前
虾米完成签到,获得积分10
21秒前
22秒前
kzx发布了新的文献求助10
22秒前
22秒前
彭于晏应助尊敬浩宇采纳,获得10
23秒前
深情安青应助zcc采纳,获得10
24秒前
小奎发布了新的文献求助10
26秒前
可爱的函函应助苏木采纳,获得10
26秒前
27秒前
郭立欣发布了新的文献求助10
27秒前
zzzcubed发布了新的文献求助10
29秒前
30秒前
30秒前
无极微光应助GGGirafe采纳,获得20
31秒前
31秒前
31秒前
31秒前
accerue应助朱子怡采纳,获得10
32秒前
33秒前
刘伟发布了新的文献求助10
34秒前
34秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6018459
求助须知:如何正确求助?哪些是违规求助? 7607110
关于积分的说明 16159240
捐赠科研通 5166074
什么是DOI,文献DOI怎么找? 2765191
邀请新用户注册赠送积分活动 1746699
关于科研通互助平台的介绍 1635359